Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

DexTech Medical AB Interim report July 1, 2022 - March 31, 2023

Summary of the third quarter (2023-01-01 – 2023-03-31) · Patient recruitment has begun for the Multiple Myeloma study · Net sales amounted to MSEK 0,0 (0,0) · Operating profit/loss amounted to MSEK -1,6 (-1,1) · Earnings per share* SEK -0.08 (-0.06) * Before and after dilution. Earnings per share: Profit for the period divided by the average number of shares 18,485,857. For the comparison period, the average number of shares was 18,485,857. Amounts in brackets refer to the corresponding period last year. Summary of the nine-month period (2022-07-01 – 2023-03-31) ·

Change in the number of shares and votes in Starbreeze AB

In accordance with Starbreeze’ articles of association, holders of series A-shares have the right to request that the shares be converted into series B-shares. Such a conversion reduces the total number of votes in the company. When such conversion has taken place, the company has an obligation according to law to publish information about any changes on a monthly basis.During the current month, at the request of shareholder’s, 552,195 shares of series A-shares have been converted into the same number of series B-shares. The total number of votes in Starbreeze then amounts to 2,203,386,648.

Arranta Bio, a Recipharm company, signs contract with MIT to develop rapid manufacturing of mRNA therapeutics

· Contract with MIT follows the largest award from FDA’s Center for Biologics Evaluation and Research office (CBER) to MIT · Potential to support better response to new pandemic threatsArranta Bio, part of Recipharm’s biologics business, has signed a contract with MIT to develop a continuous manufacturing technology for mRNA therapeutics. The contract is part of the FDA’s initiative to have a fully integrated, continuous manufacturing production line for mRNA vaccines, which the agency is funding through a contract to MIT – one of the largest awards from the FDA’s CBER office. Enabling

BioStock: Aptahem on the need for more effective sepsis treatments

Biotechnology company Aptahem is developing Apta-1, a drug candidate whose purpose is to reduce the high mortality and severe tissue damage that can occur in sepsis. BioStock contacted Luiza Jedlina, Chief Scientific Officer and co-founder of Aptahem, to talk about the need for better treatment options than antibiotics.Read the full interview with Luiza Jedlina at biostock.se: https://www.biostock.se/en/2023/04/aptahem-on-the-need-for-more-effective-sepsis-treatments/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

RugVista Group AB (publ) invitation to Rugvista’s Capital Markets Day

Rugvista welcomes investors, analysts, and financial media to a Capital Markets Day on May 25th, 2023. The Capital Markets Day will be held at our premises at Frihamnsallén 10, Malmö, with the possibility to participate digitally. Together with additional members of the company's management team, CEO Michael Lindskog will provide an update on Rugvista's current development and focus areas. Agenda for the day: Subject PresenterPresentation of Rugvista's vision, long-term Michael Lindskog, CEOstrategy, and ongoing initiatives

OrderYOYO announces capital increase, total share capital and voting rights

Company Announcement No. 52 - 2023 OrderYOYO A/SCompany announcement   Copenhagen, April 28, 2023 Capital increase, total share capital and voting rights of OrderYOYO A/S (“OrderYOYO”) With reference to company announcement no. 51 of April 17, 2023, closing of the share-for-share exchange and acquisition of shares in Kingfood has been completed. Payment to the sellers of Kingfood consists of 1,661,852 new shares in OrderYOYO and DKK 4.5m in cash. The transaction values the total share capital of Kingfood at DKK 13.4m. OrderYOYO therefore announces a directed issue of 1,

Navamedic ASA: Annual Report for 2022

Oslo, 28 April 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, announce that the company has published its Annual Report for 2022, which was approved by the Board of Directors on 27 April 2023.The report is attached to this notice and is available at navamedic.com/investors. In addition, the company has published its annual financial statements in European Single Electronic Format (ESEF).   “The year 2022 can be summarised by Navamedic successfully delivering on its growth ambition through both

SmartCraft ASA (SMCRT) re-initiates share buy-back programme

SmartCraft ASA | Additional regulated information required to be disclosed under the laws of a member state In a stock exchange announcement of 2 November 2022, SmartCraft ASA (the "Company") (Ticker: SMCRT NO) notified the initiation of a share buy-back programme to a maximum of 2% the share capital of the Company (3,430,446 shares). The buy-back programme was conducted in accordance with the authorization granted to the board of directors by the Company's Extraordinary General Meeting held on 2 November 2022. In the period 3 November 2022 to 27 April 2023 the Company purchased a total

Invitation to media and analyst briefing for BioGaia Q1 2023 report

BioGaia's (NASDAQ: BIOG) financial report for the first quarter of 2023 will be published at approximately 8:00 AM CEST on May 5, 2023. The company will issue a press release with the complete financial report attached, including tables. Following publication of the press release, the financial report will be available on BioGaia´s website . CEO Isabelle Ducellier and CFO Alexander Kotsinas will comment on the report and take questions at a live audiocast at 9:30 AM CEST. To join the audiocast with teleconference and ask a

Citycon to publish its Interim Report for January-March 2023 on Thursday, 4 May 2023 after market close

CITYCON OYJ   Investor News   28 April 2023 at 14:00 hrsCitycon will publish its Interim Report for 1 January – 31 March 2023 on Thursday, 4 May 2023 after market close. The report will be available on Citycon’s website immediately after publication.Citycon's investor, analyst and press conference call and live audiocasting will be held on Friday, 5 May 2023 at 10 am EEST. The audiocast can be participated by calling in and following live at this  website: https://citycon.videosync.fi/q1-2023/Questions for the management can be presented by phone. To ask questions, join the

New number of votes in AB Volvo

The number of votes in AB Volvo has changed due to the conversion of a total of 104 Series A shares to a total of 104 Series B shares. The conversions were implemented with the support of the opportunity for Series A shareholders to request conversion of Series A shares to Series B shares which was entered in the Articles of Association at the 2011 Annual General Meeting.Today, 28 April 2023, the last trading day of the month, there are a total of 2,033,452,084 registered shares in AB Volvo. Of these are 444,987,771 Series A shares and 1,588,464,313 Series B shares. The number of votes in

Stendörren publishes Annual and Sustainability Report for 2022

Press release April 28, 2023 The Annual and Sustainability Report for 2022 for Stendörren Fastigheter AB (publ) is now available to download on the company's website www.stendorren.se. For more information, please contact: Erik Ranje, CEO, +46 (0)70-308 52 09, erik.ranje@stendorren.se  or Per-Henrik Karlsson, CFO, +46 (0)72-158 70 92, per-henrik.karlsson@stendorren.se or visit www.stendorren.se This disclosure contains information that Stendörren Fastigheter AB is obligated to make public pursuant to the Swedish Security Markets Act. The information was submitted for

Vasakronan’s Interim Report January–March 2023

Stable results and increased rental revenue· Rental revenue increased 17% (5) to a total of SEK 2,221 million (1,902). In comparable property holdings, the increase in rental revenue was 14% (3). The increase was primarily due to completed projects and indexing. · New lettings were contracted corresponding to 23,000 square metres (44,000) and an annual rent of SEK 121 million (260). Net lettings amounted to a negative SEK 46 million (positive: 125) for the quarter and SEK 99 million (230) for the rolling 12-month period. · The price change after renegotiations averaged 5% above index (

Veidekke: To build public school and sports facility outside Stockholm

Veidekke's subsidiary Arcona has been commissioned by Botkyrka Municipality to build a new school and sports facility in Hallunda outside Stockholm. The design and build contract comprises a total area of 13,500 square meters and is valued at approx. SEK 533 million. Work on the project will start in April 2023 and is scheduled for completion in summer 2025.The new Eleonoraskolan will cater for a total of 915 pre-school to ninth grade students, and will consist of two independent buildings connected by a canopy. A separate sports facility will house school and club sports activities and a

Change in the total number of shares and votes in Sivers Semiconductors AB (publ)

As of 28 April 2023, the total number of shares and votes in Sivers Semiconductors AB (the “Company”) amounts to 234,649,894, divided into 233,549,894 ordinary shares and 1,100,000 shares of series C. The total number of votes in the Company amounts to 233,659,894.The number of shares and votes in the Company has increased as a result of the directed share issue of 20,695,650 ordinary shares resolved by the Board of Directors of the Company on 4 April 2023.  For more information please contact:Anders Storm, CEOTel: +46 70 262 6390E-mail: anders.storm@sivers-semiconductors.com

BERGENBIO ASA: Board approval of 2022 Annual Financial Statement and Annual Report 2022

Bergen, Norway – 28 April 2023 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, announces that the Board of Directors today approved the 2022 Annual Financial Statements prepared in accordance with International Financial Reporting Standards (IFRS).   The Annual Report for 2022 in pdf and European Single Electronic Format (ESEF) are attached to this release and are also available on BerGenBio ASA's website https://www.bergenbio.com/investors/reports/     Contacts: For

Decisions at the AGM of Corem Property Group AB (publ)

At the Annual General Meeting (AGM) of Corem Property Group AB on 28 April 2023 the following decisions were made, among others. Dividend The AGM decided in accordance with the Board of Directors’ proposal of a dividend of SEK 0.40 per ordinary share of Class A and Class B and SEK 20.00 per ordinary share of Class D and preference share for the 2022 financial year. The dividend amount of in total SEK 0.40 per ordinary share of Class A and Class B shall be distributed in four equal instalments of SEK 0.10 each. The dividend amount of in total SEK 20.00 per ordinary share of Class D

Resolutions at Lifco's Annual General Meeting 2023

Today, Friday 28 April 2023, the Annual General Meeting of Lifco  AB was held. The following main resolutions were made: Dividend In accordance with the proposal of the Board of Directors and the CEO, the Meeting resolved to declare a dividend of SEK 1.80 per share. Wednesday 3 May 2023 was determined as record date for dividend. Election of Board of Directors Carl Bennet, Ulrika Dellby, Annika Espander, Dan Frohm, Erik Gabrielson, Ulf Grunander, Caroline af Ugglas, Axel Wachtmeister and Per Waldemarson were re-elected members of the Board. Carl Bennet was

ANNUAL REPORT 2022 ZINZINO AB (PUBL.)

Zinzino AB (publ.) announces that the company's annual report for 2022 in Swedish is now published on the company's website, zinzino.com.  The English version will be published within approximately 45 days. The 2023 Annual General Meeting will be held at the company's premises at Hulda Mellgrens gata 5 in Västra Frölunda on May 31 at 1:30 p.m. The nomination committee's proposals for board members, the board's remuneration and auditors are presented in the notice to the annual general meeting. For further information about the annual general meeting, refer to the company's website www.

University launches scholarships for Ukrainian students

University of Wales Trinity Saint David (UWTSD) has launched new postgraduate scholarships for students from Ukraine.Ukrainian students can apply to study a Masters in Global Citizenship and Sustainable Leadership  on the University’s Lampeter Campus. All costs for postgraduate tuition, accommodation and pre-sessional language classes will be covered by UWTSD for 16 successful applicants. The Masters course is broadly built around the United Nations’ Sustainable Development Goals , and

Ponsse Plc - Managers' Transactions

Ponsse Plc, Managers’ Transactions, 28 April, 2023 at 13:30 p.m (EEST) Ponsse Plc has received the following disclosure on April 28, 2023: Person subject to the notification requirementName: Juho NummelaPosition: Chief Executive Officer Issuer: Ponsse OyjLEI: 7437000IQJS6ZC1FR041Notification type: INITIAL NOTIFICATIONReference number: 29363/4/4 Transaction date: 2023-04-27Venue: CCXEInstrument type: SHAREISIN: FI0009005078Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE Transaction details(1): Volume: 3551 Unit price: 0 EUR Aggregated

Elkem ASA - Minutes from the annual general meeting 2023

Oslo, 28 April 2023 The annual general meeting of Elkem ASA was held on 28 April 2023 in Oslo.  All proposals on the agenda were adopted, cf. the notice of the annual general meeting that was sent to the Oslo Stock Exchange on 30 March 2023. The annual general meeting approved the proposal from the board of directors to distribute a dividend of NOK 6.00 per share.  The dividend will be paid on 10 May 2023 to ordinary shareholders as of 28 April 2023, and who are listed in the Norwegian Central Securities Depository as of 3 May 2023.  The Elkem share will be traded ex-dividend from 2

Bulletin from the Annual General Meeting 2023 of Formpipe Software AB (publ)

Resolution on allocation of the company’s results and discharge from liability The Annual General Meeting (“AGM”) resolved, in accordance with the Board of Directors’ proposal, that the year’s result shall be carried forward and that no dividend shall be paid for the financial year 2022. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2022. Election of Board members, Chairperson of the Board of Directors, auditor and remuneration The AGM resolved, in accordance with the Nomination Committee’s proposal, on the following:

There are no items matching the current filter
There are no more items matching the current filter
Back to top